ICON executives say technology is a key factor in the $12 billion acquisition. PRA Health Sciences has a mobile health platform that enables patients to participate in clinical trials from their homes.
The report, by CRO Worldwide Clinical Trials, shows growing need for early-stage development expertise, with high demand for data quality, efficiency and overall trial management.
3D medical animation services have emerged as a groundbreaking tool in the healthcare industry, revolutionizing the way medical concepts are taught, understood, and marketed.
Count Icon (NASDAQ:ICLR) among the clinical research organizations continuing the industry M&A activity. The Ireland-based CRO has acquired PriceSpective, a CRO with a consulting focus and expertise in drug pricing. Icon didn’t disclose what it paid for the PriceSpective acquisition. But Outsourcing Pharma reports that William Blair analyst John Kreger among others say the deal […]